Annals of Epidemiology
Volume 11, Issue 7 , Pages 458-465 , October 2001

Coffee, Caffeine, and the Risk of Liver Cirrhosis

  • Giovanni Corrao, PhD

      Affiliations

    • Department of Statistics, Chair of Statistics in Medicine and Epidemiology, University of Milan-Bicocca, Milan, Italy
    • Corresponding Author InformationAddress correspondences to: Professor Giovanni Corrao, Dipartimento di Statistica. Università degli Studi di Milano-Bicocca. Via Bicocca degli Arcimboldi, 8, Edificio U7, 20126 Milano. Tel.: +39-02-64487354; Fax: +39-02-6473312.
    • ,
  • Antonella Zambon, BSc

      Affiliations

    • Department of Statistics, Chair of Statistics in Medicine and Epidemiology, University of Milan-Bicocca, Milan, Italy
    • ,
  • Vincenzo Bagnardi, BSc

      Affiliations

    • Department of Statistics, Chair of Statistics in Medicine and Epidemiology, University of Milan-Bicocca, Milan, Italy
    • ,
  • Amleto D'Amicis, PhD

      Affiliations

    • National Nutrition Institute, Rome, Italy
    • ,
  • Arthur Klatsky, MD

      Affiliations

    • Kaiser Permanente Medical Center, Oakland CA, USA
    • ,
  • COLLABORATIVE SIDECIR GROUP

Received 25 October 2000 ,Revised 5 February 2001 ,Accepted 7 February 2001.

References 

  1. Garattini S. Caffeine, Coffee, and Health. New York: Raven Press; 1993;
  2. Penn R, Worthington DJ. Is serum γ-glutamyltransferase a misleading test?. BMJ. 1983;286:531–535
  3. Arnesen E, Huseby NE, Brenn T, Try K. The Tromso Heart Study (Distribution of, and determinants for, gamma-glutamyltransferase in a free-living population). Scand J Clin Lab Invest. 1986;46:63–70
  4. Nilssen O, Forde OH, Brenn T. The Tromso Heart Study (Distribution and population determinants of gamma-glutamyltransferase). Am J Epidemiol. 1990;132:318–326
  5. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993;9:293–297
  6. Kono S, Shinchi K, Imanishi K, Todoroki I, Hatsuse K. Coffee and serum gamma-glutamyltransferase (A study of self-defense officials in Japan). Am J Epidemiol. 1994;139:723–727
  7. Nilssen O, Forde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase (The Tromso Study). Am J Epidemiol. 1994;139:787–792
  8. Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. Eur J Epidemiol. 1996;12:71–76
  9. Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase (Positive interaction with alcohol and body mass index, negative association with coffee). Am J Epidemiol. 1997;146:1019–1024
  10. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al.  Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol. 1998;27:438–443
  11. Aubin HJ, Laureaux C, Zerah F, Tilikete S, Vernier F, Vallat B, et al.  Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics. Biol Psychiat. 1998;44:638–643
  12. Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al.  Coffee drinking and serum gamma-glutamyltransferase (An extended study of Self-Defense Officials of Japan). Ann Epidemiol. 1999;9:325–331
  13. Klatsky AI, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136:1248–1257
  14. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, et al.  The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption (A case-control study). Eur J Epidemiol. 1994;10:657–664
  15. Corrao G, Lepore AR, Torchio P, Galatola G, Aricò S, Di Orio F. Interaction between dietary pattern and alcohol intake on the risk of liver cirrhosis. Rev Epidémiol Santé. 1995;43:7–17
  16. Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants. Application to risk factors of liver cirrhosis. Am J Epidemiol. 1995;142:1136–1146
  17. Corrao G, Torchio P, Zambon A, D'Amicis A, Lepore AR, di Orio F. Alcohol consumption and micronutrients intake as risk factors of liver cirrhosis (A case-control study). Ann Epidemiol. 1998;8:154–159
  18. Aricò S, Corrao G, D'Amicis A, Klatsky AL. Alcoholic liver cirrhosis after the advent of hepatitis C virus (Some reflections on its epidemiology and on the concept of attributable risk). It J Gastroenterol. 1997;29:75–80
  19. Litten RZ, Allen JP. Measuring Alcohol Consumption. Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press; 1992;
  20. Gilbert RM, Marshman JA, Schwieder M, Berg R. Caffeine content of beverages as consumed. Can Med Assoc J. 1976;114:205–208
  21. Carnovale E, Miuccio F. Tabelle di Composizione Degli Alimenti (in Italian). Rome: Istituto Nazionale della Nutrizione; 1989;
  22. Van Der Poel Reesing HW, Schaasberg W. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet. 1990;335:558–560
  23. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons; 1993;
  24. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989;
  25. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. I. The Analysis of Case-Control Studies. IARC Scientific Publications No. 32. Lyon: International Agency for Research on Cancer; 1980;
  26. SAS Institute, Inc . SAS Technical Report P-229, SAS/STAT Software (Changes and Enhancements, Release 6.07). Cary, NC: SAS Institute Inc; 1992;
  27. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensed and decompensed cirrhosis. Digest Dis Sci. 1986;31:468–475
  28. Corrao G, Aricò S, Russo R, Carle F, Galatola G, Torchio PF, et al.  Alcohol consumption and noncirrhotic chronic hepatitis (A case-control study). Int J Epidemiol. 1991;20:1037–1042
  29. Corrao G, Aricò S, Carle F, Russo R, Galatola G, Tabone M, et al.  A case-control study on alcohol consumption and the risk of chronic liver disease. Revue Epidemiol Santé. 1991;39:333–343
  30. Corrao G, Aricò S, Lepore AR, Valenti M, Torchio P, Galatola G, et al.  Amount and duration of alcohol intake as risk factor of symptomatic liver cirrhosis (A case-control study). J Clin Epidemiol. 1993;46:601–607
  31. Aricò S, Corrao G, Torchio P, Galatola G, Tabone M, Valenti M, et al.  A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients (A case-control study). Eur J Epidemiol. 1994;10:251–257
  32. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, et al.  Hepatitis C virus infection, HBsAg carrier state, and hepatocellular carcinoma (Relative risk and population attributable risk from a case-control study in Italy). J Hepatol. 1992;16:360–363
  33. West DW, Schuman KL, Lyon JL. Differences in risk estimation from a population-based case-control study. Int J Epidemiol. 1984;13:235–239
  34. National Institute of Statistics . Stili di Vita e Condizioni di Salute. Indagini Multiscopo Sulle Famiglie. Anni 1993–1994 (in Italian). Rome: ISTAT; 1996;
  35. Conforti P, D'Amicis A, Turrini A. Tendenze dei consumi alimentari in Italia (in Italian). Presented at the Second National Consensus Conference on Cholesterol. Rome, December 1996.
  36. Gruppo Epidemiologico della Società Italiana di Alcologia . L'impatto del consumo di alcol sulla salute degli italiani (Consumi, prevalenze, frazioni e mortalità attribuibili e prevenibili, strategie di intervento, Italia 1985–1994 (in Italian)). Alcologia. 1999;11(suppl):123–202
  37. Roig MG, Bello F, Burguillo FJ, Cachaza JM, Kennedy JF. In vitro interaction between psychotropic drugs and alcohol dehydrogenase activity. J Pharmaceutic Sci. 1991;80:267–270
  38. Corrao G, Zambon A, Torchio P, Aricò S, La Vecchia C, di Orio F. Attributable risk for symptomatic liver cirrhosis in Italy. J Hepatol. 1998;28:608–614
  39. Corrao G, Bagnardi V, Zambon A, Torchio P. A meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcoholism. 1998;33:381–392

☆ Collaborative SIDECIR (Italian Study on Liver Cirrhosis Determinants) group: Morelli D., Moscatello M.R., Stefanini G.F. (Bologna); Chiesa R., Donato F., Tomasoni V. (Brescia); Guglielmini V., Manghisi O.G., Petruzzi J. (Castellana Grotte, Bari); Boncinelli L. (Como); Bocchia M., Ribotto P., Canevelli E. (Garbagnate, Milano); Isa L., Moriglioni M. (Gorgonzola, Milano); Sardi G.F., Monica M. (Lanzo Torinese, Torino); Fasoli, Baldacci (Legnano, Milano); Andri G., Migliosi G. (Manerbio-Leno, Brescia); Ajello A., Freni M.A., Spadaro A. (Messina); Gravina M., Longo G., Mangano C. (Messina); Silvani A., Bottelli R. (Milano); Fiorelli G., Fargion S., De Feo T. (Milano); Ascione A., De Luca M., Galeota Lanza A. (Napoli); Del Vecchio Blanco G., Federico A., Loguercio C. (Napoli); Burra P., Mioni D., Naccarato R. (Padova); Guarnone F., Pallavicini C., Vittadini G. (Pavia); Aricò S. (Torino); Salvagnini M. (Vicenza), Italy

PII: S1047-2797(01)00223-X

Annals of Epidemiology
Volume 11, Issue 7 , Pages 458-465 , October 2001

Article Tools